Building Mushroom Brands | Interview with Red Light Holland CEO, Todd Shapiro

New provisional, time-limited drug approval pathway: House and Senate reintroduce bipartisan bill

Members of the House on both sides of the aisle joined with Senate colleagues late last month in reintroducing a bill that would allow for

July 8, 2023

A neuropsychologist clarifies science on aging and memory in wake of Biden special counsel report

What is the relationship between aging, memory loss, and overall cognition? That’s a matter of hot debate in the wake of special counsel Rober Hur’s

February 9, 2024

Inside a push to create an NIH office for post-infection chronic illness

When the White House released President Biden’s 2025 budget requests this week, funding for biomedical research was stagnant. The more conservative wishlist from the president

March 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.